Magyar Hematológiai és Transzfuziológiai Társaság MHTT XXII. kongresszusa
Rendezvény kezdete: 2009.05.14.Rendezvény vége: 2009.05.16. Szakterület(ek): Haematologia, haemostaseologia, Infektológia, Pathologia
Tudományos információ: Dr. Borbényi Zita Munkahely neve: SZTE II. Belgyógyászati Klinika Címe: 6720 - Szeged, Korányi fasor 6. Tel: +36 (62) 545979 E-mail: borbenyi@freemail.hu Munkahely neve: C&T Hungary Kft. Címe: 6720 Szeged, Dáni u. 13. Tel: +36 (62) 548485 Fax: +36 (62) 548485 E-mail: congress@congresstravel.hu Helyszín: 6722 Szeged, Ady tér 10., József Attila Tanulmányi és Információs Központ A rendezvény Web oldala: http://www.congresstravel.hu/mhtt2009 A kongresszus kiemelt témái:A myeloid rendszer betegségei Immunhematológiai kórképek Az őssejt transzplantáció aktuális kérdései A tanácskozás legfőbb céljának tartjuk, hogy kétévente beszámoljunk szakterületünkön elért eredményeinkről, munkánk során tapasztalt gondjainkról, betegeink legújabb kezelési lehetőségeiről. Fontos célja az összejövetelünknek, hogy segítsük egymást a hematológia és a transzfúziológia gyorsan bővülő ismeretanyagának elsajátításában és rendszerezésében, közelebb jutva egy olyan egységes szemlélethez, amely a legsúlyosabb betegek gyógyulását még eredményesebbé teheti. Helyszín: Szeged, Tanulmányi és Információs Központ , Ady tér 10. Honlap: www.congresstravel.hu/mhtt2009 Kapcsolódó dokumentumok (4)
Magyar Hypertonia Társaság The 7th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease
Rendezvény kezdete: 2020.10.15.Rendezvény vége: 2020.10.18. Helyszín: Lithuania, Vilnius, A rendezvény Web oldala: https://www.prehypertension.org/ Topics:
◾Approach to the Elderly with Borderline Metabolic Conditions
◾Arterial Properties, Central Blood Pressure and Augmentation Index in the Continuum of Prehypertension and Hypertension
◾Arterial Properties, Evaluation and Treatment in Borderline Conditions
◾Assessment of Global Cardiovascular Risk Factors in Borderline Conditions
◾Benefits of Achieving Optimal Risk Factors Level – When, How and with What?
◾Biomarkers of Borderline Conditions and Preclinical Disease
◾Borderline Cardiovascular Risk Factors - Morbidity and Mortality
◾Children and Adolescents and Cardiovascular Risk Factors- Diagnosis, Estimation of Risk and Treatment
◾Complications of Prehypertension, Hypertension and Cardiometabolic Syndrome: the Heart, the Brain, the Kidney and the Extremities
◾Cumulative Effects of Multiple Borderline Cardiometabolic Risk Factors
◾Diabetes, Prevention, Mechanisms and Treatment of end Organ Damage
◾Humoral Factors in Prehypertension and Cardiometabolic Syndrome
◾Hypertension, Mechanisms and Therapeutic Approach
◾Management of Dyslipidemia, Mechanisms and Novel Therapeutic Regimens
◾Metabolic Syndrome and Borderline Metabolic Conditions
◾Natural History of Prehypertension, Hypertension and End Organ Damage
◾Obesity, Mechanisms and Therapy
◾Prediabetes – Mechanism, Diagnosis, and Management
◾Prehypertension and Metabolic Syndrome in Different Populations – Epidemiology
◾Prehypertension, Cause and Results
◾Prehypertension, Prediabetes and Dyslipidemia – Estimation of Risk and Therapeutic Approach
◾Prehypertension – Progression of Risk and Diagnosis of Disease
◾Prehypertension- Mechanism, Diagnosis and Management
◾Prevention and Regression of End Organ Damage in Prehypertension
◾The Heart, the Brain and the Kidney in Prehypertension and Cardiometabolic Syndrome
◾Total Cardiovascular Risk Evaluation and Management
Magyar Hypertonia Társaság The 7th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease
Rendezvény kezdete: 2020.10.15.Rendezvény vége: 2020.10.18. Helyszín: Lithuania, Vilnius, A rendezvény Web oldala: https://www.prehypertension.org/ Topics:
◾Approach to the Elderly with Borderline Metabolic Conditions
◾Arterial Properties, Central Blood Pressure and Augmentation Index in the Continuum of Prehypertension and Hypertension
◾Arterial Properties, Evaluation and Treatment in Borderline Conditions
◾Assessment of Global Cardiovascular Risk Factors in Borderline Conditions
◾Benefits of Achieving Optimal Risk Factors Level – When, How and with What?
◾Biomarkers of Borderline Conditions and Preclinical Disease
◾Borderline Cardiovascular Risk Factors - Morbidity and Mortality
◾Children and Adolescents and Cardiovascular Risk Factors- Diagnosis, Estimation of Risk and Treatment
◾Complications of Prehypertension, Hypertension and Cardiometabolic Syndrome: the Heart, the Brain, the Kidney and the Extremities
◾Cumulative Effects of Multiple Borderline Cardiometabolic Risk Factors
◾Diabetes, Prevention, Mechanisms and Treatment of end Organ Damage
◾Humoral Factors in Prehypertension and Cardiometabolic Syndrome
◾Hypertension, Mechanisms and Therapeutic Approach
◾Management of Dyslipidemia, Mechanisms and Novel Therapeutic Regimens
◾Metabolic Syndrome and Borderline Metabolic Conditions
◾Natural History of Prehypertension, Hypertension and End Organ Damage
◾Obesity, Mechanisms and Therapy
◾Prediabetes – Mechanism, Diagnosis, and Management
◾Prehypertension and Metabolic Syndrome in Different Populations – Epidemiology
◾Prehypertension, Cause and Results
◾Prehypertension, Prediabetes and Dyslipidemia – Estimation of Risk and Therapeutic Approach
◾Prehypertension – Progression of Risk and Diagnosis of Disease
◾Prehypertension- Mechanism, Diagnosis and Management
◾Prevention and Regression of End Organ Damage in Prehypertension
◾The Heart, the Brain and the Kidney in Prehypertension and Cardiometabolic Syndrome
◾Total Cardiovascular Risk Evaluation and Management
Magyar Hypertonia Társaság The 7th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease
Rendezvény kezdete: 2020.10.15.Rendezvény vége: 2020.10.18. Helyszín: Lithuania, Vilnius, A rendezvény Web oldala: https://www.prehypertension.org/ Topics:
◾Approach to the Elderly with Borderline Metabolic Conditions
◾Arterial Properties, Central Blood Pressure and Augmentation Index in the Continuum of Prehypertension and Hypertension
◾Arterial Properties, Evaluation and Treatment in Borderline Conditions
◾Assessment of Global Cardiovascular Risk Factors in Borderline Conditions
◾Benefits of Achieving Optimal Risk Factors Level – When, How and with What?
◾Biomarkers of Borderline Conditions and Preclinical Disease
◾Borderline Cardiovascular Risk Factors - Morbidity and Mortality
◾Children and Adolescents and Cardiovascular Risk Factors- Diagnosis, Estimation of Risk and Treatment
◾Complications of Prehypertension, Hypertension and Cardiometabolic Syndrome: the Heart, the Brain, the Kidney and the Extremities
◾Cumulative Effects of Multiple Borderline Cardiometabolic Risk Factors
◾Diabetes, Prevention, Mechanisms and Treatment of end Organ Damage
◾Humoral Factors in Prehypertension and Cardiometabolic Syndrome
◾Hypertension, Mechanisms and Therapeutic Approach
◾Management of Dyslipidemia, Mechanisms and Novel Therapeutic Regimens
◾Metabolic Syndrome and Borderline Metabolic Conditions
◾Natural History of Prehypertension, Hypertension and End Organ Damage
◾Obesity, Mechanisms and Therapy
◾Prediabetes – Mechanism, Diagnosis, and Management
◾Prehypertension and Metabolic Syndrome in Different Populations – Epidemiology
◾Prehypertension, Cause and Results
◾Prehypertension, Prediabetes and Dyslipidemia – Estimation of Risk and Therapeutic Approach
◾Prehypertension – Progression of Risk and Diagnosis of Disease
◾Prehypertension- Mechanism, Diagnosis and Management
◾Prevention and Regression of End Organ Damage in Prehypertension
◾The Heart, the Brain and the Kidney in Prehypertension and Cardiometabolic Syndrome
◾Total Cardiovascular Risk Evaluation and Management